Subsys Pushes Insys Therapeutics (INSY) to 3Q Beat; Piper Jaffray Reiterates Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Insys Therapeutics (INSY) Tops Q3 EPS by 27c
November 5, 2015 8:00 AM ESTInsys Therapeutics (NASDAQ: INSY) reported Q3 EPS of $0.50, $0.27 better than the analyst estimate of $0.23. Revenue for the quarter came in at $91.3 million versus the consensus estimate of $82.98 million.
For earnings history and earnings-related data on Insys Therapeutics (INSY) click here.
... MoreInsys Therapeutics (INSY) CEO Babich Steps Down
November 5, 2015 6:59 AM ESTInsys Therapeutics, Inc. (NASDAQ: INSY) announced that Michael L. Babich has stepped down as President and Chief Executive Officer of Insys. The Board of Directors has appointed Dr. John N. Kapoor as President and Chief Executive Officer effective November 4, 2015. Dr. Kapoor will continue to serve of the Chairman of the Companys Board of Directors. Daniel Brennan has been appointed Executive Vice President and Chief Operating Officer effective November 1, 2015.
It has been a privilege to lead Insys for the past six... More
Insys Therapeutics (INSY) Approves $50M Common Stock Buyback
November 5, 2015 6:53 AM ESTInsys Therapeutics (Nasdaq: INSY) announced that its Board of Directors has approved the repurchase of up to $50 million of the Company's common stock.
"The Board of Directors and management team believe that shares of Insys stock are an attractive investment opportunity, and we... More
Trading Radar for 11/5: Disney (DIS), Celgene (CELG), SeaWorld (SEAS), Sprouts (SFM), CyberArk (CYBR) Report
November 4, 2015 3:11 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
A.M. Castle & Co. (NYSE: CAS) - no Street consensus
ACI Worldwide, Inc. (Nasdaq: ACIW) - consensus EPS $0.11
AES Corp (NYSE: AES) - consensus EPS $0.38
ANSYS... More
Insys Therapeutics (INSY) Pressured Following CNBC Report
November 4, 2015 9:49 AM ESTInsys Therapeutics (NASDAQ: INSY) shares were pressured following a cautious CNBC report.
The company is accused of pushing an addictive painkillers that is supposed to be used only in cancer pain.
... More